|
US3340276A
(en)
|
1964-04-01 |
1967-09-05 |
Ciba Geigy Corp |
3, 4-diphenyl-chromans
|
|
DE1518002C3
(de)
|
1965-01-02 |
1975-01-23 |
Merck Patent Gmbh, 6100 Darmstadt |
Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
|
|
DE1543749A1
(de)
|
1966-02-16 |
1969-12-11 |
Merck Ag E |
Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
|
|
GB1433013A
(enExample)
|
1973-06-08 |
1976-04-22 |
|
|
|
US4218489A
(en)
|
1977-06-08 |
1980-08-19 |
Z-L Limited Partnership |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
|
US4264509A
(en)
|
1977-06-08 |
1981-04-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
|
US4157984A
(en)
|
1977-06-08 |
1979-06-12 |
Z-L Limited |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
|
US4232122A
(en)
|
1979-01-17 |
1980-11-04 |
Z-L Limited Partnership |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
|
US4234577A
(en)
|
1979-03-19 |
1980-11-18 |
Z-L Limited Partnership |
Ergostadientriols, compositions containing same, and methods of preparing and using same
|
|
US4368264A
(en)
|
1979-03-19 |
1983-01-11 |
Z-L Limited Partnership |
Fermentation methods of preparing ergostadientriols
|
|
US4366248A
(en)
|
1979-04-11 |
1982-12-28 |
Z-L Limited Partnership |
Fermentation method of preparing antioxidants
|
|
US4390559A
(en)
|
1979-04-11 |
1983-06-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
|
US4366082A
(en)
|
1979-04-11 |
1982-12-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
|
US4447622A
(en)
|
1981-09-22 |
1984-05-08 |
Council Of Scientific And Industrial Research Rafi Marg |
Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
|
|
US4644012A
(en)
|
1983-12-21 |
1987-02-17 |
Takeda Chemical Industries, Ltd. |
Treatment for osteoporosis
|
|
GB8626344D0
(en)
|
1986-11-04 |
1986-12-03 |
Zyma Sa |
Bicyclic compounds
|
|
MX13485A
(es)
|
1987-10-19 |
1993-05-01 |
Pfizer |
Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos
|
|
US5059609A
(en)
|
1987-10-19 |
1991-10-22 |
Pfizer Inc. |
Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
|
EP0470310B1
(en)
|
1990-08-09 |
1995-11-29 |
Council of Scientific and Industrial Research |
Novel benzopyrans and process for their production
|
|
WO1994008986A1
(en)
|
1992-10-21 |
1994-04-28 |
Pfizer, Inc. |
Enantiomeric cis-3-(4,6-dihydroxychroman-3-yl-methyl)benzoic acids
|
|
US5280040A
(en)
|
1993-03-11 |
1994-01-18 |
Zymogenetics, Inc. |
Methods for reducing bone loss using centchroman derivatives
|
|
US5451603A
(en)
|
1993-03-11 |
1995-09-19 |
Zymogenetics, Inc. |
3,4-diarylchromans for treatment of dermatitis
|
|
US5389646A
(en)
|
1993-12-30 |
1995-02-14 |
Zymogenetics, Inc. |
Methods for treatment and prevention of bone loss using 2,3-benzopyrans
|
|
US5792776A
(en)
|
1994-06-27 |
1998-08-11 |
Cytomed, Inc., |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
BR9606754A
(pt)
|
1995-01-13 |
1998-01-06 |
Novo Nordisk As |
Uso de compostos processo para tratamento e profilaxia de ginecomastia idiopática ou fisiológia e novo detalhe característico ou combinação de detalhes
|
|
CZ212397A3
(en)
|
1995-01-13 |
1997-11-12 |
Novo Nordisk As |
Use of 3,4-diphenylchromans for preparing pharmaceutical preparations for treating or prophylaxis of hyperlipoproteinaemia, hypertriacylglycerolaemia, hyperlipidaemia, hypercholesterolaemia, arteriosclerosis and reduction of blood sedimentation
|
|
HUP9702244A3
(en)
|
1995-01-13 |
1999-12-28 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders
|
|
TW448046B
(en)
|
1995-01-20 |
2001-08-01 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
|
|
WO1996022093A1
(en)
|
1995-01-20 |
1996-07-25 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
|
|
BR9606766A
(pt)
|
1995-01-20 |
1997-12-30 |
Novo Nordisk As |
Utilização de compostos e processo para o tratamento e profilaxia de disturbios degenerativos cerebrais
|
|
US5849461A
(en)
|
1995-08-01 |
1998-12-15 |
Shin-Etsu Chemical Co., Ltd. |
Chemically amplified positive resist composition
|
|
US5726202A
(en)
|
1996-01-11 |
1998-03-10 |
Novo Nordisk A/S |
Benign prostatic hypertrophy
|
|
US5883118A
(en)
|
1996-01-11 |
1999-03-16 |
Nova Nordisk A/S |
Prostatic carcinoma
|
|
US5747059A
(en)
|
1996-01-11 |
1998-05-05 |
Novo Nordisk A/S |
Atrophy of skin/mucous membrane
|
|
AU1367297A
(en)
|
1996-01-11 |
1997-08-01 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical comp osition for the treatment or prophylaxis of menopausal symptoms
|
|
US5756539A
(en)
|
1996-07-11 |
1998-05-26 |
Novo Nordis A/S |
3, 4-diphenyl chromans for inhibiting one or more psychiatric disorders
|
|
EP0921797A1
(en)
|
1996-07-12 |
1999-06-16 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for lowering intraocular pressure
|
|
AU3433797A
(en)
|
1996-07-12 |
1998-02-09 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
|
|
AUPO203996A0
(en)
|
1996-08-30 |
1996-09-26 |
Novogen Research Pty Ltd |
Therapeutic uses
|
|
GB9621757D0
(en)
|
1996-10-18 |
1996-12-11 |
Ciba Geigy Ag |
Phenyl-substituted bicyclic heterocyclyl derivatives and their use
|
|
US5985306A
(en)
|
1996-10-28 |
1999-11-16 |
Novo Nordisk A/S |
(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
|
|
JP2002503213A
(ja)
|
1996-10-28 |
2002-01-29 |
ノボ ノルディスク アクティーゼルスカブ |
エストロゲン関連疾患または症候群の防止または治療に有用な新規なｃｉｓ―３，４―クロマン誘導体
|
|
JP2001502708A
(ja)
|
1996-10-28 |
2001-02-27 |
ノボ ノルディスク アクティーゼルスカブ |
エストロゲン関連の疾患または症候群の予防または治療に有用な新規なシス―３，４―クロマン誘導体
|
|
EP0937059A1
(en)
|
1996-10-28 |
1999-08-25 |
Novo Nordisk A/S |
NOVEL $i(TRANS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
|
|
US6043269A
(en)
|
1996-10-28 |
2000-03-28 |
Novo Nordisk A/S |
cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
ES2188909T3
(es)
|
1996-10-28 |
2003-07-01 |
Novo Nordisk As |
Nuevos derivados de cis-3,4-cromano utiles para la prevencion o tratamiento de sindromes o enfermedades relacionados con el estrogeno. os
|
|
CA2270111A1
(en)
|
1996-10-28 |
1998-05-07 |
Lise Brown Christiansen |
Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
US5994390A
(en)
|
1996-10-28 |
1999-11-30 |
Novo Nordisk |
Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
EP0937056A1
(en)
|
1996-10-28 |
1999-08-25 |
Novo Nordisk A/S |
A process for the preparation of (-)-3,4-trans-diarylchromans
|
|
US5919817A
(en)
|
1996-10-28 |
1999-07-06 |
Novo Nordisk A/S |
Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
ZA979644B
(en)
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
|
US5958967A
(en)
|
1996-10-28 |
1999-09-28 |
Novo Nordisk A/S |
Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
IL129618A0
(en)
|
1996-10-28 |
2000-02-29 |
Novo Nordisk As |
Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
EP0937058A1
(en)
|
1996-10-28 |
1999-08-25 |
Novo Nordisk A/S |
NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
|
|
US6316494B1
(en)
|
1996-10-28 |
2001-11-13 |
Novo Nordisk A/S |
cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
ATE225782T1
(de)
|
1996-12-13 |
2002-10-15 |
Chugai Pharmaceutical Co Ltd |
Benzopyranderivate
|
|
ZA98682B
(en)
|
1997-01-29 |
1998-07-29 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders
|
|
WO1998033499A1
(en)
|
1997-01-29 |
1998-08-06 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for increasing libido in post-menopausal women
|
|
WO1998033500A1
(en)
|
1997-01-29 |
1998-08-06 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting senescence-associated motor impairment
|
|
US5874418A
(en)
|
1997-05-05 |
1999-02-23 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
|
|
AUPP112497A0
(en)
|
1997-12-24 |
1998-01-22 |
Novogen Research Pty Ltd |
Compositions and method for protecting skin from UV induced immunosupression and skin damage
|
|
WO1999049862A1
(en)
|
1998-03-30 |
1999-10-07 |
The University Of Mississippi |
Isoflavones for treating giardiasis and malaria
|
|
JP2002512807A
(ja)
|
1998-04-28 |
2002-05-08 |
ノボ ノルディスク アクティーゼルスカブ |
（−）−３．４−トランス−ジアリールクロマンを得るための酵素的分割
|
|
FR2778404B1
(fr)
|
1998-05-06 |
2000-06-30 |
Hoechst Marion Roussel Inc |
Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant
|
|
US6465445B1
(en)
|
1998-06-11 |
2002-10-15 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
|
KR20000001793A
(ko)
|
1998-06-13 |
2000-01-15 |
이경하 |
신규한 벤조피란 또는 티오벤조피란 유도체
|
|
US6509323B1
(en)
|
1998-07-01 |
2003-01-21 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
|
FR2789685B1
(fr)
|
1999-02-15 |
2001-05-04 |
Univ Lille Sciences Tech |
Procede de fabrication de polymeres solubles et insolubles a base de cyclodextrine(s) et/ou de derives de cyclodextrine(s) et polymeres solubles a base de cyclodextrine(s) et/ou de derives de cyclodextrine(s)
|
|
AUPP868599A0
(en)
|
1999-02-15 |
1999-03-11 |
Novogen Research Pty Ltd |
Production of isoflavone derivatives
|
|
AUPQ008299A0
(en)
|
1999-04-30 |
1999-05-27 |
G.J. Consultants Pty Ltd |
Isoflavone metabolites
|
|
WO2001007031A1
(en)
|
1999-07-26 |
2001-02-01 |
Shionogi & Co., Ltd. |
Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same
|
|
AUPQ266199A0
(en)
|
1999-09-06 |
1999-09-30 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
|
US6528042B1
(en)
|
1999-10-08 |
2003-03-04 |
Galileo Laboratories, Inc. |
Compositions of flavonoids for use as cytoprotectants and methods of making and using them
|
|
AU7896100A
(en)
|
1999-10-14 |
2001-04-23 |
Endorecherche Inc. |
Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance
|
|
AU1888001A
(en)
|
1999-12-13 |
2001-06-18 |
Chugai Seiyaku Kabushiki Kaisha |
Optically active chroman and thiochroman derivatives
|
|
US6479467B1
(en)
|
1999-12-16 |
2002-11-12 |
Eastman Chemical Company |
Cyclodextrin ethers
|
|
RU2342145C2
(ru)
|
2000-01-28 |
2008-12-27 |
Андорешерш, Инк. |
Селективные модуляторы рецептора эстрогена в комбинации с эстрогенами
|
|
ATE319480T1
(de)
|
2000-05-11 |
2006-03-15 |
Eastman Chem Co |
Acylierte zyklodextrin guest-inklusion komplexe
|
|
FI20001593A7
(fi)
|
2000-07-03 |
2002-01-04 |
Orion Yhtymo Oyj |
Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia
|
|
CN1250505C
(zh)
|
2000-08-31 |
2006-04-12 |
科学工业研究院 |
制备1－丙基－2，4，5－三甲氧基苯的改进方法
|
|
AU2002241823A1
(en)
|
2001-01-11 |
2002-07-24 |
Eastman Chemical Company |
Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials
|
|
IL157065A0
(en)
|
2001-01-24 |
2004-02-08 |
Chiesi Farma Spa |
2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
|
|
CA2437851C
(en)
|
2001-02-14 |
2011-05-17 |
Akzo Nobel Nv |
2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
|
|
CZ2004220A3
(cs)
|
2001-08-11 |
2004-06-16 |
Bristol-Myers Squibb Pharma Company |
Název neuveden
|
|
ATE476178T1
(de)
|
2001-09-06 |
2010-08-15 |
Synorx Inc |
Hemmung der t-lymphozyten-aktivierung durch 3- deoxyflavonoide und relevante therapien
|
|
AUPR846401A0
(en)
|
2001-10-25 |
2001-11-15 |
Novogen Research Pty Ltd |
6-Hydroxy isoflavones, derivatives and medicaments involving same
|
|
EP1465619A1
(en)
|
2002-01-14 |
2004-10-13 |
Nordic Bioscience A/S |
Suppression of cartilage degradation via the estrogen receptor
|
|
EP1503751A4
(en)
|
2002-04-09 |
2007-08-01 |
Novogen Res Pty Ltd |
THERAPEUTIC PROCESSES AND COMPOSITIONS WITH ISOFLAV-3-EN AND ISOFLAVAN STRUCTURES
|
|
AU2002951833A0
(en)
|
2002-10-02 |
2002-10-24 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods invloving platinum complexes
|
|
WO2004032862A2
(en)
|
2002-10-09 |
2004-04-22 |
Insert Therapeutics, Inc. |
Cyclodextrin-based materials, compositions and uses related thereto
|
|
WO2005049627A1
(en)
|
2003-11-18 |
2005-06-02 |
Novogen Research Pty Ltd |
Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
|
|
JP2007525485A
(ja)
|
2003-11-19 |
2007-09-06 |
ノボゲン リサーチ ピーティーワイ リミテッド |
複合的な放射線治療及び化学治療の組成物及び方法
|
|
DE102004002787A1
(de)
|
2004-01-19 |
2005-08-11 |
Merck Patent Gmbh |
Flavonoid-Komplexe
|
|
ATE532777T1
(de)
|
2004-09-21 |
2011-11-15 |
Marshall Edwards Inc |
Substituierte chromanderivate, medikamente und anwendungen in der therapie
|
|
WO2006032086A1
(en)
|
2004-09-21 |
2006-03-30 |
Novogen Research Pty Ltd |
Chroman derivatives, medicaments and use in therapy
|
|
JP4976649B2
(ja)
|
2004-09-21 |
2012-07-18 |
マーシャル エドワーズ，インク． |
化合物
|
|
US8080675B2
(en)
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
|
ES2516067T3
(es)
|
2004-09-21 |
2014-10-30 |
Mei Pharma, Inc. |
Derivados de cromano sustituidos, medicamentos y utilización en terapia
|
|
WO2008052256A1
(en)
|
2006-10-30 |
2008-05-08 |
Novogen Research Pty Ltd |
Prevention and reversal of chemotherapy-induced peripheral neuropathy
|
|
WO2008113100A1
(en)
|
2007-03-16 |
2008-09-25 |
Novogen Research Pty Ltd |
Method for inducing autophagy
|
|
EP2334296A4
(en)
|
2008-08-29 |
2012-04-25 |
Novogen Res Pty Ltd |
IMMUNOMODULATING ACTIVITIES
|
|
CA2641541A1
(en)
|
2008-10-22 |
2010-04-22 |
Novogen Research Pty Ltd. |
Methods for inducing programmed cell death
|
|
EP2362773A4
(en)
|
2008-10-22 |
2012-05-09 |
Novogen Res Pty Ltd |
METHOD FOR TRIGGERING PROGRAMMED CELL DEATH
|
|
CA2816322A1
(en)
|
2010-11-01 |
2012-05-10 |
Marshall Edwards, Inc. |
Isoflavonoid compositions and methods for the treatment of cancer
|
|
US20120251630A1
(en)
|
2011-03-29 |
2012-10-04 |
Marshall Edwards, Inc. |
Remission therapy of cancer with isoflavonoids
|
|
BR112015006363A2
(pt)
|
2012-09-28 |
2017-08-08 |
Boehringer Ingelheim Int |
combinações farmacêuticas compreendendo ligantes angiopoietina-2/dll4 duplos e agentes anti-vegf-r
|
|
PL2953938T3
(pl)
|
2014-02-07 |
2017-12-29 |
Novogen Ltd. |
Funkcjonalizowane związki benzopiranowe i ich zastosowanie
|
|
CN107427003B
(zh)
*
|
2015-02-02 |
2023-01-31 |
梅制药公司 |
联合治疗
|